This inventor holds 5 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Chiesi Farmaceutici S.p.a., Genentech, Inc., F. Hoffmann-La Roche Ag. Active years: 2013-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Slough, GB (2013)
- Macclesfield, GB (2013)
- Harlow, GB (2013 - 2015)
Company Filing History:



Years Active: 2013-2015
Title: Bohdan Waszkowycz: Innovator in Pharmaceutical Compounds
Introduction
Bohdan Waszkowycz, based in Harlow, GB, is a notable inventor with an impressive portfolio of five patents to his name. His work primarily focuses on the development of novel pharmaceutical compounds that target specific disorders mediated by lipid kinases.
Latest Patents
Among his recent innovations, one of the key patents is for Benzoxazepin compounds selective for PI3K P110 delta and methods of use. This invention includes Benzoxazepin Formula I compounds, which encompass a range of stereoisomers, geometric isomers, tautomers, metabolites, and pharmaceutically acceptable salts. These compounds are designed to inhibit the delta isoform of PI3K, providing therapeutic options for treating disorders such as inflammation, immunological disorders, and cancer. The patent elaborates on methodologies for using these compounds in various diagnostic and therapeutic contexts in mammalian cells.
Another significant patent filed by Waszkowycz pertains to heterocyclic compounds and their methods of use. Similar to the previous patent, this innovation revolves around Formula I compounds that inhibit the delta isoform of PI3K, outlining their potential in the diagnosis, prevention, and treatment of related disorders.
Career Highlights
Throughout his career, Bohdan Waszkowycz has contributed to the field of pharmaceuticals by working with esteemed organizations such as Genentech, Inc. and Chiesi Farmaceutici S.p.a. His expertise in drug development and innovative thinking has positioned him as a key player in the exploration of cancer and immunological treatments.
Collaborations
Waszkowycz has collaborated with prominent colleagues in his field, including Robert Andrew Heald and Brian Salvatore Safina. These partnerships have further enriched his research endeavors and expanded the potential applications of his inventions.
Conclusion
Bohdan Waszkowycz's contributions to the realm of pharmaceutical innovations through his patents highlight his significant role as an inventor. His work not only aims to advance medical science but also seeks to provide hope for patients suffering from complex disorders. As he continues to explore and innovate, the impact of his inventions may lead to transformative treatments for numerous health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile